Quantcast

Latest Tacrolimus Stories

2015-05-04 08:27:51

Data presented at the American Transplant Congress HORSHOLM, Denmark, May 4, 2015 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that once-daily Envarsus(®) XR (tacrolimus

2015-01-14 16:24:58

HORSHOLM, Denmark, Jan. 14, 2015 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) (Veloxis) today confirmed that the U.S.

2015-01-13 04:21:22

HORSHOLM, Denmark, Jan. 13, 2015 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) (Veloxis) today confirmed that it has received notice from the U.S.

2014-12-19 12:25:09

HORSHOLM, Denmark, Dec. 19, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) (Veloxis) today issued the following statement regarding an order issued by the U.S.

2014-11-24 08:27:58

DUBLIN, Nov. 24, 2014 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has agreed to market the authorized generic version of Astellas U.S.

2014-11-20 04:22:07

TARRYTOWN, N.Y. and PARIS, Nov. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.

2014-11-12 12:31:42

HORSHOLM, Denmark, Nov. 12, 2014 /PRNewswire/ -- Highlights: -- On 31 October the U.S.

2014-07-28 13:28:02

Oxford University scientists have shown that a powerful drug given at the time of a kidney transplant operation not only halves the early risk of rejection, but that it also allows a less toxic regimen of anti-rejection drugs to be used after the operation.